Join our panel of experts as they share their insights and experiences with canine parvovirus, and learn how monoclonal antibody therapy may improve survival and recovery outcomes
EP. 1: Meet the canine parvovirus panel
The panel shares their credentials and breadth of expertise
Watch
EP. 2: How Parvo is wreaking havoc on the pet community
Our panel weighs in on the heavy toll of this devastating disease
EP. 3: COVID-19's impact on Parvo management
Panelists discuss how Parvo management changed during the COVID-19 pandemic
EP. 4: The learning process while managing Parvo
How Parvo affects the human/animal bond
EP. 5: Parvo and hospital morale
Panelists discuss how to boost hospital morale while managing Parvo cases
EP. 6: Socialization for puppies affected by Parvo
The panel explains how Parvo affects early development for puppies and shares advice for pet parents
EP. 7: The new canine Parvovirus monoclonal antibody
Panelists share their excitement regarding the new canine Parvovirus monoclonal antibody
EP. 8: Comparing CPMA with previous treatment options
How CPMA works and how it differs from pre-existing treatment options
EP. 9: Contraindications to consider during treatment
Contraindications and things to look out for while using CPMA for treatment
EP. 10: Optimizing the use of CPMA to best treat patients
Panelists share their experiences with using CPMA for Parvo treatment
EP. 11: How CPMA affects survivability
The panel discusses how CPMA impacts survivability, hospital morale, and the human/animal bond
EP. 12: Limitations during Parvo treatment
How cost, accessibility, and patient condition affect treatment
EP. 13: Looking into the future of Parvo treatment
How monoclonal antibodies like CPMA can help change the future of veterinary medicine